Given that recent studies have shown an association between hypoglycemic events and risk cardiovascular events [24], our study may suggest that adding liraglutide to insulin is advantageous from a cardiovascular standpoint owing to its reduced frequency of hypoglycemia compared to treatment with insulin only. Here, INS is linked to Hypoglycemia.